PlasmidFactory GmbH, founded in 2000 in Bielefeld, Germany, is a leading European Contract Development and Manufacturing Organization (CDMO) specializing in plasmid and Minicircle DNA for research, pre-clinical, and clinical applications. As an independent and flexible partner, the company supports customers worldwide with a focus on gene and cell therapy. PlasmidFactory provides custom DNA in quality tiers ranging from Scientific (SQ) to High Quality (HQ) to GMP Grade. Its state-of-the-art facilities and GMP plant ensure the highest purity and compliance with global standards. In addition, a broad in-stock portfolio offers AAV helper and packaging plasmids, reporter constructs, and molecular markers. Proprietary technologies such as ITRRESCUE®, ITRPROTECT®, POLYARESUE®, MIDGE® Vectors, and advanced QC reflect PlasmidFactory’s commitment to innovation. With over 25 years of experience, more than 3,500 successful projects, and a 99.9 % success rate, PlasmidFactory is a trusted partner for advancing gene-based innovation.

Company (Headquarters):

Germany

Types of Drugs Manufactured:

Cell & Gene Therapy

CDMO Services:

Research & Development

Therapeutic Area:

Central Nervous System;Hematology;Immunology;Infectious Disease;Oncology;Platform Technologies;Rare and Genetic Disorders;Respiratory

CDMO Number of Facilities:

3

Facilities Location:

Europe

Manufacturing Technologies:

Sterile Vials

Current Capacity:

PlasmidFactory provides custom and in stock DNA in quality tiers ranging from Scientific (SQ) to High Quality (HQ) to GMP Grade from mid to large scale.